Company Overview of Eyetech Inc.
Eyetech Inc., a biotechnology company, develops products for the treatment of sight-threatening diseases of the retina. It offers Macugen, a pegaptanib sodium injection/anti-VEGF inhibitor that is used for the treatment of neovascular age-related macular degeneration. The company also offers Macugen access programs that assist patients with reimbursement. It markets and sells Macugen in the United States. Eyetech Inc. was founded in 2008 and is based in Cedar Knolls, New Jersey. As of February 13, 2012, Eyetech Inc. operates as a subsidiary of Valeant Pharmaceuticals International, Inc.
140 East Hanover Avenue
Cedar Knolls, NJ 07927
Founded in 2008
Key Executives for Eyetech Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Eyetech Inc., please visit www.eyetech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.